IOSP Stock Analysis: Innospec | NASDAQ
Specialty Chemicals | NASDAQ, USA | Market Cap: 2.304m USD | 12M Return: 14.2% | US45768S1050 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 15.1M
EPS Trend: -75.7%
Qual. Beats: 1
Rev. Trend: -85.5%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Innospec Inc. (NASDAQ: IOSP) is a U.S.-based specialty chemicals company headquartered in Englewood, Colorado. Founded in 1938 and formerly known as Octel Corp., the company develops, manufactures, blends, and markets chemical products for customers across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. Its business is organized into three operating segments: Performance Chemicals, Fuel Specialties, and Oilfield Services.
The Fuel Specialties segment supplies additives for diesel, jet, marine, fuel oil, and other fuels used in commercial trucking, aviation, marine engines, power generation, and industrial machinery. The Performance Chemicals segment delivers technology-based solutions into personal care, home care, agrochemical, construction, and mining markets, while the Oilfield Services segment provides chemical solutions for drilling, completion, production, and other oil and gas applications.
Innospec serves a diverse customer base that includes large multinational manufacturers, fuel marketers and retailers, marine operators, plastics and coatings producers, and exploration and production companies. As a specialty chemicals producer within the broader materials sector, the company operates on a business-to-business model, supplying formulated chemical additives and process solutions rather than bulk commodity chemicals, which typically allows for higher value-added pricing tied to technical performance and customer-specific applications.
- Fuel Specialties margins benefit from marine sulfur regulations
- Oilfield Services revenue softens with weaker drilling activity
- Share buybacks accelerate earnings per share growth
| Net Income: 121.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.30 > 1.0 |
| NWC/Revenue: 35.64% < 20% (prev 35.31%; Δ 0.33% < -1%) |
| CFO/TA 0.07 > 3% & CFO 125.5m > Net Income 121.5m |
| Net Debt (-202.3m) to EBITDA (171.5m): -1.18 < 3 |
| Current Ratio: 2.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (24.7m) vs 12m ago -1.34% < -2% |
| Gross Margin: 27.46% > 18% (prev 28.40%; Δ -0.94% > 0.5%) |
| Asset Turnover: 100.9% > 50% (prev 99.15%; Δ 1.73% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.36 (Total Current Assets 1.02b - Total Current Liabilities 368.1m) / Total Assets 1.85b |
| B: 0.62 (Retained Earnings 1.14b / Total Assets 1.85b) |
| C: 0.08 (EBIT TTM 139.5m / Avg Total Assets 1.83b) |
| D: 2.71 (Book Value of Equity 1.34b / Total Liabilities 495.2m) |
| Altman-Z'' = 7.70 = AAA |
| DSRI: 1.18 (Receivables 408.6m/336.1m, Revenue 1.84b/1.79b) |
| GMI: 1.03 (GM 28.40% / 27.46%) |
| AQI: 0.96 (AQ_t 0.26 / AQ_t-1 0.27) |
| SGI: 1.03 (Revenue 1.84b / 1.79b) |
| TATA: -0.00 (NI 121.5m - CFO 125.5m) / TA 1.85b) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of August 23, 2026, the stock is trading at USD 93.63 with a total of 114,320 shares traded. Over the past week, the price has changed by -0.23%, over one month by +10.80%, over three months by +18.93% and over the past year by +14.17%.
Current recommended Stop Loss: 90.90 (which is 2.9% or 1.3 ATR below the current price).
Innospec has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy IOSP.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 101 | 7.9% |
P/E Trailing = 19.0939
P/E Forward = 18.5529
P/S = 1.251
P/B = 1.7222
P/EG = 0.6612
Revenue TTM = 1.84b USD
EBIT TTM = 139.5m USD
EBITDA TTM = 171.5m USD
Long Term Debt = 33.6m USD (estimated: total debt 47.9m - short term 14.3m)
Short Term Debt = 14.3m USD (from shortTermDebt, last quarter)
Debt = 47.9m USD (from shortLongTermDebtTotal, last quarter) (leases 47.9m already included)
Net Debt = -202.3m USD (calculated: Debt 47.9m - CCE 250.2m)
Enterprise Value = 2.10b USD (2.30b + Debt 47.9m - CCE 250.2m)
Interest Coverage Ratio = unknown (Ebit TTM 139.5m / Interest Expense TTM 0.0)
EV/FCF = 32.39x (Enterprise Value 2.10b / FCF TTM 64.9m)
FCF Yield = 3.09% (FCF TTM 64.9m / Enterprise Value 2.10b)
FCF Margin = 3.52% (FCF TTM 64.9m / Revenue TTM 1.84b)
Net Margin = 6.60% (Net Income TTM 121.5m / Revenue TTM 1.84b)
Gross Margin = 27.46% ((Revenue TTM 1.84b - Cost of Revenue TTM 1.34b) / Revenue TTM)
Gross Margin QoQ = 28.14% (prev 27.25%)
Tobins Q-Ratio = 1.14 (Enterprise Value 2.10b / Total Assets 1.85b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 47.9m)
Taxrate = 14.65% (21.0m / 143.3m)
NOPAT = 119.1m (EBIT 139.5m * (1 - 14.65%))
Current Ratio = 2.78 (Total Current Assets 1.02b / Total Current Liabilities 368.1m)
Debt / Equity = 0.04 (Debt 47.9m / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = -1.18 (Net Debt -202.3m / EBITDA 171.5m)
Debt / FCF = -3.12 (Net Debt -202.3m / FCF TTM 64.9m)
Total Stockholder Equity = 1.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.65% (Net Income 121.5m / Total Assets 1.85b)
RoE = 9.15% (Net Income TTM 121.5m / Total Stockholder Equity 1.33b)
RoCE = 10.25% (EBIT 139.5m / Capital Employed (Equity 1.33b + L.T.Debt 33.6m))
RoIC = 8.50% (NOPAT 119.1m / Invested Capital 1.40b)
WACC = 8.21% (E(2.30b)/V(2.35b) * Re(8.38%) + D(47.9m)/V(2.35b) * Rd(0.0%) * (1-Tc(0.15)))
Discount Rate = 8.38% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.14 | Cagr: -0.64%
[DCF] Terminal Value 73.10% ; FCFF base≈73.7m ; Y1≈64.6m ; Y5≈52.2m
[DCF] Fair Price = 42.24 (EV 838.2m - Net Debt -202.3m = Equity 1.04b / Shares 24.6m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -75.69 | EPS CAGR: -8.10% | SUE: 2.62 | # QB: 1
Revenue Correlation: -85.52 | Revenue CAGR: -3.48% | SUE: 1.50 | # QB: 2
EPS current Quarter (2026-09-30): EPS=1.27 | Chg30d=+2.42% | Revisions=+40% | Analysts=3
EPS current Year (2026-12-31): EPS=4.94 | Chg30d=+3.28% | Revisions=+40% | GrowthEPS=-6.3% | GrowthRev=+7.1%
EPS next Year (2027-12-31): EPS=6.15 | Chg30d=+1.26% | Revisions=+25% | GrowthEPS=+24.6% | GrowthRev=+5.9%
[Analyst] Revisions Ratio: +62% (up=5, down=0)